Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · IEX Real-Time Price · USD
1.510
+0.050 (3.42%)
At close: Jul 12, 2024, 4:00 PM
1.540
+0.030 (1.99%)
After-hours: Jul 12, 2024, 7:55 PM EDT

Clover Health Investments Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018
Revenue
2,0343,4771,472672.89462.27
Upgrade
Revenue Growth (YoY)
-41.50%136.19%118.76%45.56%59.06%
Upgrade
Cost of Revenue
1,7693,3601,662572.95457.22
Upgrade
Gross Profit
264.57116.25-189.8199.935.04
Upgrade
Selling, General & Admin
444.73486.64445.75192.09187.33
Upgrade
Other Operating Expenses
28.391.261.440.560.91
Upgrade
Operating Expenses
473.11487.9447.18192.64188.24
Upgrade
Operating Income
-208.54-371.65-636.99-92.71-183.2
Upgrade
Interest Expense / Income
0.011.333.1935.9923.16
Upgrade
Other Expense / Income
4.81-33.41-52.437.7157.38
Upgrade
Pretax Income
-213.36-339.57-587.76-136.39-363.74
Upgrade
Net Income
-213.36-339.57-587.76-136.39-363.74
Upgrade
Shares Outstanding (Basic)
4824764138988
Upgrade
Shares Outstanding (Diluted)
4824764138988
Upgrade
Shares Change
1.25%15.34%365.57%0.98%109.06%
Upgrade
EPS (Basic)
-0.44-0.71-1.42-1.54-4.14
Upgrade
EPS (Diluted)
-0.44-0.71-1.42-1.54-4.14
Upgrade
Free Cash Flow
-116.46-290.82-283.05-119.19-159.9
Upgrade
Free Cash Flow Per Share
-0.24-0.61-0.69-1.34-1.82
Upgrade
Gross Margin
13.01%3.34%-12.89%14.85%1.09%
Upgrade
Operating Margin
-10.25%-10.69%-43.27%-13.78%-39.63%
Upgrade
Profit Margin
-10.49%-9.77%-39.93%-20.27%-78.69%
Upgrade
Free Cash Flow Margin
-5.73%-8.36%-19.23%-17.71%-34.59%
Upgrade
EBITDA
-210.85-337.05-583.32-99.85-340.03
Upgrade
EBITDA Margin
-10.37%-9.69%-39.63%-14.84%-73.56%
Upgrade
Depreciation & Amortization
2.511.191.250.560.55
Upgrade
EBIT
-213.35-338.23-584.56-100.4-340.58
Upgrade
EBIT Margin
-10.49%-9.73%-39.71%-14.92%-73.68%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).